Background Thyroglobulin is a well-established disease marker during follow-up in
paediatric differentiated thyroid cancer. However, no conclusive data on the role of …

Context Whether radioactive iodine therapy (RAIT) is necessary for intermediate-risk
papillary thyroid cancer (PTC) after total thyroidectomy is still lacking reliable evidence …

Purpose This multicentric study aimed to investigate the main prognostic factors associated
with treatment response at 1 year after radioactive iodine therapy (RAIT) and the last …

Purpose In pediatric patients with differentiated thyroid cancer (DTC) we assessed the
prognostic value of the 12-month response to therapy after initial treatment with surgery and …

Objective To analyze prognostic factors in children with differentiated thyroid carcinoma
(DTC) who have been treated in a single center in the last 27 years. Methods We studied …

Hyperthyroidism is a clinical condition characterized by low thyroid-stimulating hormone
(TSH) blood levels and normal or higher blood levels of triiodothyronine (FT3) and thyroxine …

The theragnostic approach was proposed with the introduction of 131-Iodine for the
treatment of both benign and malign thyroid diseases [1–5]. The therapeutic effect of 131 …

Well-differentiated thyroid carcinoma is predominantly a slow-growing malignancy,
amendable to treatment, and has an excellent prognosis following thyroidectomy and …

In the adult population, the differentiated thyroid cancer (DTC) is the most frequent
endocrine neoplasm [1]. According to the American Thyroid Association (ATA) guidelines, in …

Differentiated thyroid cancer (DTC) represents the most frequent endocrine neoplasm,
accounting for 5% of thyroid nodules [1]. The standard treatment of patients with DTC …